{"id":"anti-rankl-monoclonal-antibody","phase":"phase_1","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypersensitivity"},{"rate":"null","effect":"Infection"},{"rate":"null","effect":"Infusion-related reaction"}]},"status":"active","trials":["NCT03550508"],"aliases":["JMT103"],"patents":[],"pricing":[],"timeline":[],"aiSummary":"Inhibits RANKL Used for Osteoporosis.","brandName":"Anti-RANKL Monoclonal Antibody","companyId":"shanghai-jmt-bio-inc","mechanism":{"_ai_source":"groq-llama-8b","explanation":"RANKL inhibition prevents osteoclast formation and bone resorption.","oneSentence":"Inhibits RANKL","_ai_confidence":"medium"},"commercial":null,"companyName":"Shanghai JMT-Bio Inc.","competitors":[],"genericName":"Anti-RANKL Monoclonal Antibody","indications":{"approved":[{"name":"Osteoporosis"}]},"labelChanges":[],"trialDetails":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"rwe":[],"genericFilers":[],"relatedDrugs":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"modality":"Biologic","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}